Back to search

Peptide record

TPDB41124

P06 Anticancer standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41124
P06
Anticancer
Cancer-related peptides
CancerPPD 2.0
standard
No
A 18-aa standard natural anticancer peptide sequence curated from CancerPPD 2.0, with an available 3D structural model.
Sequence
GAGTGGLGLAVEGPSEAK
Physicochemical Analysis
C66H111N19O25
RNDCQHIMFWY
G
1570.72
4.26
1
2
6
-1
4.25
0.044
76.11
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
3
A
0
R
0
N
0
D
0
C
2
E
0
Q
6
G
0
H
0
I
2
L
1
K
0
M
0
F
1
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 0 D: 0 C: 0 E: 2 Q: 0 G: 6 H: 0 I: 0 L: 2 K: 1 M: 0 F: 0 P: 1 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
18
C66H111N19O25
1570.72
4.26
-1
4.25
0.044
Free
L
Linear
Free
Anticancer
FLNA (Filamin A) fragment
Evidence Records 2 records
Evidence 1 Activity

Activity

Relative viability
Relative viability = 0.92 at 50 µg/ml
Anticancer

Target

Bone Cancer
MG-63
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

Relative viability
Relative viability = 1.17 at 50 µg/ml
Anticancer

Target

Bone Cancer
U-2 OS
Bone

Assay & Model

MTT assay
48-h

Source & Reference

CancerPPD 2.0
CancerPPD2
2023